Showing results (31-40 of 2,459) with videos related to
Sort By:
Pageof 246
Biostatistics (Oxford, England)|April 16, 2005
Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiationPeter B Gilbert, Yanqing SunBiometrics|April 27, 2011
Comparing biomarkers as principal surrogate endpointsYing Huang, Peter B GilbertScandinavian Journal of Statistics, Theory and Applications|March 23, 2013
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing MarksYanqing Sun, Peter B GilbertLifetime Data Analysis|March 24, 2016
Joint modeling of longitudinal and survival data with the Cox model and two-phase samplingRong Fu, Peter B GilbertJournal of Virology|October 18, 2005
How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?W David Wick, Otto O Yang, Lawrence Corey, et al.Journal of Immunological Methods|September 9, 2006
Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trialsZoe Moodie, Yunda Huang, Lin Gu, et al.The Journal of Infectious Diseases|February 3, 2005
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trialPeter B Gilbert, Michael L Peterson, Dean Follmann, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Nomenclature for immune correlates of protection after vaccinationStanley A Plotkin, Peter B GilbertBiometrics|April 29, 2009
Assessing vaccine effects in repeated low-dose challenge experimentsMichael G Hudgens, Peter B GilbertBiostatistics (Oxford, England)|December 17, 2013
Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacyErin E Gabriel, Peter B GilbertPageof 246